FDA approves 1st drug for rare skin condition

The FDA on May 19 approved the first drug to treat patients with dystrophic epidermolysis bullosa — a rare genetic disorder that causes fragile skin and persistent sores. 

Read the full post at Becker's Hospital Review - Healthcare News